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Abstract: Four simple, rapid and sensitive spectrophotometric methods have been proposed for the determination of 
enalapril maleate in pharmaceutical formulations. The ﬁ  rst method is based on the reaction of carboxylic acid group of 
enalapril maleate with a mixture of potassium iodate (KIO3) and iodide (KI) to form yellow colored product in aqueous 
medium at 25 ± 1°C .The reaction is followed spectrophotometrically by measuring the absorbance at 352 nm. The second, 
third and fourth methods are based on the charge transfer complexation reaction of the drug with p-chloranilic acid (pCA) 
in 1, 4-dioxan-methanol medium, 2, 3-dichloro 5, 6-dicyano 1, 4-benzoquinone (DDQ) in acetonitrile-1,4 dioxane medium 
and iodine in acetonitrile-dichloromethane medium. Under optimized experimental conditions, Beer’s law is obeyed in the 
concentration ranges of 2.5–50, 20–560, 5–75 and 10–200 μg mL
−1, respectively. All the methods have been applied to the 
determination of enalapril maleate in pharmaceutical dosage forms. Results of analysis are validated statistically.
Keywords: enalapril maleate, spectrophotometry, validation, commercial dosage forms
Introduction
Enalapril maleate is chemically described as 1-[N-[(S) - 1 –carboxy- 3-phenylpropyl] L - proline 
1’- ethyl ester, maleate (1:1). Its molecular weight is 492.53. Enalapril maleate is a prodrug; following 
oral administration, it is bioactivated by hydrolysis of ethyl ester to enalaprilat, which is the active 
angiotensin converting enzyme inhibitor. It lowers peripheral vascular resistance without causing an 
increase in the heart rate. It is an ideal drug for hypersensitive patients who are intolerant to beta-block-
ers. The drug is used for treating high blood pressure or hypertension in adults and children and conges-
tive heart failure. The drug and their tablets are ofﬁ  cial in USP 24 (1), which describes HPLC method 
for its quantitation.
The therapeutic importance of enalapril maleate was behind the development of numerous methods 
for its determination. The methods adopted to the analysis of enalapril maleate include high-performance 
liquid chromatography (2–9), capillary electrophoresis (10), liquid chromatography- tandem mass 
spectrometry (11), polarography (12), atomic absorption spectrometry (13) and membrane selective 
electrodes (14). 
Few spectrophotometric methods have also been reported for the determination of enalapril maleate 
in commercial dosage forms. The cited drug after dissolving in distilled water exhibits an absorbance 
maximum at 207 nm and this property has been exploited to develop a UV method for its quantitation 
(15). Enalapril maleate reacts with 2, 4-dinitroﬂ  urobenzene at pH 9 yielding a colored product which 
absorbs maximally at 356 nm forming a basis for its determination (12). Spectrophotometric methods 
based on the ternary complex formation between copper (II), eosin (13); palladium (II), eosin (16) and 
enalapril maleate have been reported. The spectrophotometric methods reported for analysis of enalapril 
maleate in commercial dosage forms suffered disadvantage of heating at 100 °C (12) and long analysis 
time (16). Considering this drawback, there was a need to develop more advantageous spectrophoto-
metric methods for its determination in commercial dosage forms.
This paper describes four sensitive, fast, simple and economical methods for the determination of 
enalapril maleate in dosage forms. The ﬁ  rst method is based on the reaction of carboxylic acid group 
of enalapril maleate with a mixture of potassium iodate and iodide. The second, third and fourth meth-
ods are based on the charge transfer complexation reaction of the drug with pCA in 1, 4-dioxan-methanol 32
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medium, DDQ in acetonitrile-1,4 dioxan medium 
and iodine in acetonitrile-dichloromethane 
medium
Experimental
Apparatus
Spectral runs were made on Spectronic 20D
+ Spec-
trophotometer (Milton Roy Company, USA) with 
1 cm matched glass cells.
Materials and reagents
•  Enalapril maleate was kindly provided by Sunij 
Pharma Pvt. Ltd., Ahmedabad, India and was 
used as received.
•  Pharmaceutical preparations of enalapril 
maleate such as enapril (Intas Pharmaceuticals 
Pvt. Ltd., India), envas (Cadila Pharmaceuticals 
Ltd., India) and enace (Nicholas Primal India 
Ltd.) were purchased from local market.
•  Potassium iodide (s.d. Fine-Chem Ltd, Mumbai, 
India) solution was prepared as 5.0 × 10
−2 M 
solution in distilled water.
•  Potassium iodate (Central Drug House (P) Ltd, 
New Delhi, India) solution was also prepared 
as 3.0 × 10
−3 M solution in distilled water.
•  pCA (Central Drug House (P) Ltd, New Delhi, 
India) was prepared as 0.2% (w/v) solution in 
1,4-dioxan.
•  DDQ (Fluka Chemie AG, Germany) was pre-
pared as 0.1% (w/v) solution in 1, 4-dioxan.
•  Iodine (Merck Limited, Mumbai, India) was 
prepared as 0.1% (w/v) solution in dichloro-
methane.
Standard drug solutions
Enalapril maleate standard solutions were prepared 
as 0.5 mg mL
−1 solution in distilled water for 
Method A, 2.0 mg mL
−1 in methanol for Method 
B, 0.5 mg mL
−1 in acetonitrile for Method C and 
1.0 mg mL
−1 in acetonitrile for Method D.
Procedure for determination
Method A
Aliquots of enalapril maleate standard solution 
(0.5 mg mL
−1) containing 25–500 μg were trans-
ferred into a series of 10 mL volumetric ﬂ  asks. To 
each ﬂ  ask, 1 mL of 3.0 × 10
−3 M potassium iodate 
and 1.5 mL of 5.0 × 10
−2 M potassium iodide were 
added and diluted to volume with distilled water. 
The reaction was allowed to proceed at 25 ± 1 °C 
and absorbance was measured as a function of time 
at 352 nm against reagent blank prepared simultane-
ously. The calibration curve was constructed by 
plotting the ∆ A (absorbance measured at 8.0 
min—absorbance measured at 2 min) against the 
initial concentration of enalapril maleate. The con-
tent of enalapril maleate was calculated either from 
the calibration curve or corresponding regression 
equation.
Method B
Into a series of 5 mL volumetric ﬂ  asks, volumes of 
enalapril maleate standard solution (2.0 mg mL
−1) 
equivalent to 0.1–2.8 mg of the drug were trans-
ferred. To each ﬂ  ask, 2.5 mL of 0.2% pCA was 
added and brought up to the volume with 1,4 
dioxan . The colored product formed immediately 
at room temperature (25 ± 1 °C) and absorbance 
was measured after 2 min of mixing at 510 nm 
against the reagent blank prepared similarly omit-
ting the drug.
Method C
The aliquots of enalapril maleate standard solution 
(0.5 mg mL
−1) equivalent to 25–375 μg of the drug 
were transferred into a series of 5 mL volumetric 
ﬂ  asks. To each ﬂ  ask, 1.4 mL of 0.1% DDQ was 
added and brought up to the volume with acetoni-
trile.The color developed immediately at room 
temperature (25 ± 1 °C) and the absorbance was 
measured after 3 min at 565 nm against the reagent 
blank prepared similarly omitting the drug.
Method D
The volumes of enalapril maleate standard solution 
(1.0 mg mL
−1) corresponding to 50–1000 μg of the 
drug were transferred into a series of 5 mL ﬂ  asks. 
1.2 mL of 0.1% iodine was added in each ﬂ  ask at room 
temperature (25 ± 1 °C) and diluted up to the mark 
with dichloromethane. The absorbance was measured 
after 2 min at 365 nm against the reagent blank.
Analysis of pharmaceutical 
formulations
Twenty tablets (claming for 2.5 mg of enalapril 
maleate per tablet) were finely powdered and 33
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extracted separately into sufficient volume of 
water, methanol or acetonitrile with shaking. The 
residue was ﬁ  ltered on Whatmann ﬁ  lter paper No. 
42 and the ﬁ  ltrate was diluted to 50 mL with water, 
methanol or acetonitrile, as the case may be. It was 
further diluted according to the need and then 
analyzed following the proposed procedures.
Results and Discussion
Reaction with a mixture of iodide
and iodate
It has been reported in the literature (17) that iodine 
is formed as a result of the interaction of a mixture 
of iodide and iodate with inorganic or organic acid 
in accordance with the equation:
  56 3 3 32 2 II O H H OI
−− + ++ → +  
In aqueous solution, the iodide ions react 
with the liberated iodine to yield triiodide ion 
() II I 23 +→
−−  which absorbs maximally at 290 nm 
and 360 nm. We thought that this reaction would 
be helpful for developing a spectrophotometric 
method for determination of enalapril maleate as 
it contains –COOH group in its moiety. Keeping 
this in mind, a mixture of potassium iodide and 
potassium iodate was allowed to react with enala-
pril maleate which yielded iodine. Then the liber-
ated iodine reacted with the excess of iodide ion 
resulting in the formation triiodide ion with λmax 
at 352 nm. The reaction sequence is shown in 
Scheme 1.
Reaction with σ-acceptor
The absorption spectrum of iodine in dichloromethane 
showed only one peak with maximum absorption 
at 500 nm. The color of iodine changes to yellow 
upon reaction with enalapril maleate.This is due to 
charge transfer complexation reaction between 
enalapril maleate and iodine. The absorption 
spectrum of enalapril maleate-iodine reaction 
product showed absorption peaks at 290 and 365 
nm. The stoichiometry of the reaction was studied 
by Job’s method of continuous variations. It was 
observed from the Figure 1 that the combining 
molar ratio between enalapril maleate and iodine 
is 1:1. It has been reported that the charge-transfer 
complex between drug and iodine (18) would have 
an ionized structure DI
+ … I3
−. The absorption 
spectrum of this charge-transfer complex is identical 
to that of I3
− in dichloromethane as it also absorbed 
at 290 nm and 360 nm. On the basis of our 
experimental ﬁ  ndings and the literature background, 
the reaction mechanism is proposed and given in 
Scheme 2.
Reaction with π-acceptors
The interaction of enalapril maleate with π-acceptors 
such as p-CA and DDQ at room temperature was 
found to yield colored charge transfer complexes. In 
polar solvents, complete electron transfer from 
enalapril maleate (D), as an electron donor, to the 
acceptor moiety (A) takes place resulting in the 
formation of intensely colored radical anions. The 
reaction sequence can be shown as:
     Polar  solvent 
    D + A     (D − A)    D
.+ + A
.−
    complex     radical ions
The absorption spectra of enalapril maleate- π-
acceptor reaction mixtures showed absorption 
peaks which were similar to the maxima of the 
radical anions of the π-acceptors obtained by the 
iodide reduction method (19).
The literature reveals that pCA exists in three 
forms:(i) H2A at very low pH which is yellow-
orange in color, (ii) HA
−, dark purple, which is 
stable at pH 3, and (iii) colorless A
−2 which is 
stable at high pH. The interconversion of these 
species can be represented as:
IO3
- + 5I
-
+
+   3I2        +      3H  2  O
O
N
N
HOOC
O
O O H3C
H
CH3
Enalapril maleate
6
Aqueous  medium
O
N
N
OOC
O
O O H3C
H
CH3
-
6
3 2 I I I
Scheme 1.34
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 H 2A U H
+ + HA
− (violet) 
 HA
− U H
+ + A
− (colorless) 
The interaction of enalapril maleate with pCA 
in methanol-1,4-dioxan solvent system resulted in 
the formation of violet colored charge transfer 
complex and the absorption spectrum exhibited 
maximum absorption at 510 nm. The reaction 
stoichiometry between enalapril maleate and pCA 
was evaluated by applying Job’s method of con-
tinuous variations. The Job’s plot (Fig. 1) reached 
a maximum value at a mole fraction of 0.5 which 
suggested a donor (enalapril maleate) to acceptor 
(pCA) ratio of 1:1. On the basis of reaction stio-
chiometry and literature background, the reaction 
mechanism is presented in scheme 3.
The interaction of enalapril maleate with DDQ 
resulted in the formation of colored charge-
transfer complex. The dissociation of charge-
transfer complex was promoted by the high 
ionizing power of the acetonotrile-1, 4-dioxan 
solvent system where complete electron transfer 
from enalapril maleate to the DDQ moiety takes 
place. This is followed by the formation of the 
DDQ radical anion as predominant chromogen 
which absorbed maximally at 430, 535 and 565 nm. 
In order to avoid the maximum interference from 
the blank, the absorption band at λmax 565 nm was 
chosen for analytical studies. The Job’s plot 
(Fig. 1) indicated a donor to acceptor ratio of 1:1. 
On the basis of this study and literature survey, 
the formation of DDQ radical anion is shown in 
Scheme 4.
The association constants and apparent molar 
absorptivities of pCA-enalapril maleate, DDQ-
enalapril maleate and iodine-enalapril maleate 
charge transfer complexes have been calculated 
using Ross and Labes equation (20), which depends 
on the experimental condition that acceptor con-
centration should not low enough to be considered 
negligible with respect to donor concentration.
 
[] []
[][] [][]
AD
ADAK AD +
×=
∈
×
+
+
∈
11 1 1
λλ λ
 (1)
where [A] and [D] are total concentrations of 
the acceptor and donor, respectively. Aλ and ελ are 
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Figure 1. Job’s plot for stoichiometric ratio between enalaparil maleate and pCA (4.06 × 10
−3 M each), DDQ (2.03 × 10
−3 M each) or Iodine 
(3.94 × 10
−3 M each).35
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the absorbance and apparent molar absorptivity of 
the complex at wavelength λ. K is the association 
constant of the charge transfer complex.
[] []
[][]
AD
AD A + ×
1
λ  is plotted against 
1
[][] AD +  (Fig. 2) 
which gave a straight line. The intercept and slope 
were calculated and equation (1) is transformed 
into the following equations:
for pCA – enalapril maleate system
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for DDQ – enalapril maleate system
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for Iodine – enalapril maleate system
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The association constants and molar absorp-
tivities were found to be 3.826 × 10
3 and 1.203 × 10
3 
Lmol
−1cm
−1 for pCA-enalapril maleate complex 
from equation (2), 5.124 × 10
3 and 6.095 × 10
3 
Lmol
−1cm
−1 for DDQ-enalapril maleate complex 
from equation (3) and 1.543 × 10
3 and 7.291 × 10
3 
Lmol
−1cm
−1 for iodine- enalapril maleate complex 
from equation (4), respectively. The free energy 
change was also calculated and found to 
be –20.44 KJmol
−1 for pCA-enalapril maleate 
complex, –21.17 KJmol
−1 for DDQ-enalapril 
maleate complex and –18.19 KJmol
−1 for iodine- 
enalapril maleate complex.
Optimizations of variables
The different parameters affecting the color devel-
opment were extensively studied to determine the 
optimum conditions for the assay procedures. The 
optimum values of the variables were maintained 
throughout the determination process.
Method A
Effect of the concentration
of potassium iodate
The effect of the volume of 3.0 × 10
−3 M potassium 
iodate on the absorbance of the product was stud-
ied in the range of 0.2 –1.2 mL. The absorbance 
           +      I2
          .  I2
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 - +      I2
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2-
-
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Figure 2. Plot of 1/[D0] vs [A0]/A
AD for Methods B, C and D.36
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increases with increase in the volume of KIO3 and 
became constant at 0.8 mL. Further addition of 
KIO3 does not change the absorbance and therefore, 
1.0 mL of 3.0 × 10
−3 M KIO3 was chosen as an 
optimum value (Fig. 3).
Effect of the concentration
of potassium iodide
The effect of the volume of 5.0 × 10
−2 M potassium 
iodide on the intensity of the colored product was 
studied in the range of 0.2– 1.8 mL, keeping the 37
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constant concentrations of enalapril maleate 
(50 μg mL
−1) and KIO3 (3.0 × 10
−4 M). The maximum 
absorbance was obtained with 1.2 mL; further 
addition caused no change on the absorbance. 
Thus, 1.5 mL of 5.0 × 10
−2 M potassium iodide 
was used throughout the experiment (Fig. 4).
Method B
Effect of reaction time
Optimum reaction time was evaluated by 
monitoring the color development at room 
temperature. It was observed that the reaction got 
stabilized within 2 min. The developed color 
remained stable at room temperature for about a 
further 1 h.
Effect of pCA concentration
To study the effect of the volume of the reagent 
on the absorbance of the charge transfer complex, 
varying volumes of 0.2% pCA was mixed with 
1.5 mL of 0.2% drug in a 5 mL standard ﬂ  ask 
and diluted to volume with 1, 4-dioxan. The 
results (Fig. 5) showed that the highest absorbance 
was obtained with 2.2 mL, which remained unaf-
fected by further addition of pCA. Hence, 2.5 mL 
of the reagent was used for the determination.
Method C
Effect of reaction time
The interaction of DDQ with enalapril maleate 
resulted in the formation of colored product which 
stabilized within 2 min.The developed color 
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Figure 3. Effect of the volume of 3.0 × 10
−3 M potassium iodate on 
the absorbance of the product (enalapril maleate 50 μg mL
−1; 1.5 mL 
of 5.0 × 10
−2 KI).
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Figure 4. Effect of the volume of 5.0 × 10
−2 M potassium iodide on 
the absorbance of the product (enalapril maleate 50 μg mL
−1; 1.0 mL 
of 3.0 × 10
−3 KIO3).
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Figure 5. Effect of the volume of 0.2% pCA, 0.1% DDQ and 0.1% 
Iodine on the absorbance (600 μg mL
−1 enalapril maleate for pCA, 
50 μg mL
−1 enalapril maleate for DDQ and 100 μg mL
−1 enalapril 
maleate for iodine).39
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remained stable at room temperature for about a 
further 2 h.
Effect of DDQ concentration
To establish the optimum experimental condition, 
enalapril maleate (250 μg) was allowed to react 
with different volumes (0.05–1.8 mL) of 0.05% 
DDQ. The results (Fig. 5) showed that the highest 
absorbance was obtained with 1.0 mL, which 
remained unaffected by further addition of DDQ. 
Hence, a volume of 1.4 mL of the reagent was used 
for the determination.
Method D
Effect of reaction time
In method D, the colored product was formed 
immediately and remained stable at room tem-
perature for about 1 h. The absorbance was mea-
sured after 2 min. of mixing the reagent.
Effect of iodine concentration
In order to study the effect of the volume of 0.1% 
iodine on the absorbance of the charge transfer 
complex, varying volumes (0.05–1.2 mL) were 
treated, separately with 500 μg of enalapril maleate.
The results are shown in Fig. 5 which indicated that 
0.8 mL of 0.1% iodine gave the maximum absor-
bance and remained constant by further addition of 
iodine. Therefore, a volume of 1.2 mL was chosen 
as an optimum value for the determination.
Validation of proposed methods
Under the optimum experimental conditions, 
the calibration graphs were constructed by 
plotting Δ A (Δ A = absorbance measured at 
8.0 min—absorbance measured at 2 min) or 
absorbance as a function of initial concentration 
of enalapril maleate for methods A; and B, C and 
D, respectively. The method of least square was 
applied to yield the regression equations. Results 
are summarized in Table 1. It is apparent from 
the table 1 that the sensitivity of the proposed 
methods follows the order: ACDB. In all 
cases, calibration plots (n = 11 ) were linear with 
small intercepts (1.32 × 10
−4 ± 6.52 × 10
−4), 
(9.36 × 10
−6 ± 2.43 × 10
−3), (6.98 × 10
−4  ± 
1.55 × 10
−3) and (−8.76 × 10
−4 ± 4.12 × 10
−3) 
and good correlation coefﬁ  cients (0.9998–0.9999). 
The LOD values obtained for methods A, B, C 
and D were 1.13, 3.07, 0.39 and 3.20 μg mL
−1 
respectively. The small values of the variance 
2.13 × 10
−7, 3.03  × 10
−6, 1.04  × 10
−6 and 
9.06 × 10
−6 μg mL
−1for methods A, B, C and D 
respectively (Table 1) confirmed the small 
degree of scatter of experimental data points 
around the line of regression.
Accuracy and precision
The within day precision was evaluated through 
replicate analysis (n = 5) of quality control samples: 
20, 35 and 50 μg mL
-1 for method A and 120, 280 
and 440 μg mL
-1 for method B and 20, 40 and 60 μg 
mL
-1 for method C and 40, 100 and 160 μg mL
-1 for 
method D. The percentage recoveries ranged 
from 99.96–100.08% with RSD from 0.284%–0.845%, 
99.96%–100.02% with RSD from 0.122%–0.242%, 
99.96%–100.04% with RSD from 0.250%–
0.481% and 100.01%–100.06% with RSD from 
0.142%–0.440%for methods A, B, C and D 
respectively. The interday precision was also 
evaluated through replicate analysis of the quality 
control samples for ﬁ  ve consecutive days at the same 
concentration levels as used in within day precision. 
The percentage recoveries for methods A, B, C and 
D ranged from 99.98%–100.11% with RSD from 
0.482%–1.098%, 99.91%–99.96% with RSD from 
0.184%–0.373%, 99.89%–100.00% with RSD 
from 0.373%–0.872% and 100.01%–100.06% with 
RSD from 0.318%–0.918% respectively (Table 2). 
The results in the Table 2 indicated the high precision 
of the proposed methods. The selectivity of the 
proposed methods was investigated by observing any 
interference encountered from the excipients of the 
tablets such as lactose, starch, cellulose, magnesium 
stearate, ferric oxide, talc and calcium carbonate and 
hydrochlorothiazide which is present with enalapril 
maleate in pharmaceutical products. It was observed 
that the excipients and hydrochlorothiazide did not 
interfere with the proposed methods.
The proposed methods were applied to the 
determination of enalapril maleate in commercial 
tablets such as Enapril 2.5, Envas 2.5 and Enace 
2.5. The same batch of the commercial dosage 
forms was also analyzed by the reference method 
(12). The results of the proposed methods were 
compared with those obtained by the reference 
method. Statistical analysis of the results using 
Student’s t-test, variance ratio F-test and interval 
hypothesis test (21) revealed no significant 
difference between the proposed method ( A, B, C 40
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Table 2. Test of precision of the proposed methods A, B, C and D.
Proposed methods Concentration, (μg mL
−1) Recovery RSD
a SAE
b CL
c
Taken  Found ± SD (%) (%)
Method A
Intraday assay 20 19.99 ± 0.169 99.96 0.845 0.076 0.210
35 35.03 ± 0.133 100.08 0.378 0.059 0.165
50 50.01 ± 0.142 100.03 0.284 0.063 0.176
Interday assay 20 20.02 ± 0.220 100.11 1.098 0.098 0.273
35 35.00 ± 0.169 100.00 0.482 0.076 0.210
50 49.99 ± 0.270 99.98 0.538 0.120 0.334
Method B
Intraday assay 120 119.99 ± 0.290 99.99 0.242 0.130 0.360
280 279.89 ± 0.478 99.96 0.171 0.214 0.594
440 440.10 ± 0.535 100.02 0.122 0.239 0.664
Interday assay 120 119.89 ± 0.447 99.91 0.373 0.200 0.555
280 279.89 ± 0.610 99.96 0.217 0.273 0.757
440 439.78 ± 0.811 99.95 0.363 0.363 1.007
Method C
Intraday assay 20 20.00 ± 0.096 100.00 0.481 0.043 0.119
40 40.01 ± 0.113 100.04 0.283 0.051 0.141
60 59.98 ± 0.150 99.96 0.250 0.067 0.186
Interday assay 20 19.98 ± 0.174 99.89 0.872 0.078 0.216
40 39.99 ± 0.149 99.98 0.373 0.067 0.185
60 60.00 ± 0.244 100.00 0.406 0.109 0.303
Method D
Intraday assay 40 40.02 ± 0.176 100.06 0.440 0.079 0.219
100 100.05 ± 0.269 100.06 0.269 0.121 0.335
160 160.02 ± 0.228 100.01 0.142 0.102 0.283
Interday assay 40 40.02 ± 0.367 100.06 0.918 0.164 0.456
100 100.05 ± 0.420 100.06 0.420 0.188 0.521
160 160.02 ± 0.509 100.01 0.318 0.228 0.632
aRSD, relative standard deviations (n = 5).
bSAE, standard analytical error.
cCL, conﬁ  dence limit at 95% conﬁ  dence level.
Table 1. Optical characteristics and statistical data of the regression equations for methods A, B, C and D.
Parameters Method A Method B Method C Method D
λmax (nm) 352 510 565 365
Beer’s law limit (μg mL
−1) 2.5–50 20.0–560 5–75 10–200
Linear regression
equation
ΔA = 1.32 × 10
−4+
1.35 × 10
−3 C
A = 9.36 × 10
−6 +
1.87 × 10
−3 C
A = 6.98 × 10
−4+
8.70 × 10
−3 C
A = −8.76 × 10
−4 +
3.11 × 10
−3 C
tSa 6.15 × 10
−4 2.30 × 10
−3 1.46 × 10
−3 3.88 × 10
−3
tSb 2.11 × 10
−5 6.37 × 10
−6 3.13 × 10
−5 6.53 × 10
−3
Correlation coefﬁ  cient (r) 0.9998 0.9999 0.9999 0.9999
Variance (S0
2) 2.13 × 10
−7 3.03 × 10
−6 1.04 × 10
−6 9.06 × 10
−6
Detection limit (μg mL
−1) 1.13 3.07 0.39 3.20
± t S, Conﬁ  dence limit for intercept.
± t S, Conﬁ  dence limit for slope.
n = 11, t (ΰ = 10) = 2.22841
Determination of enalapril maleate by Spectrophotometry
Analytical Chemistry Insights 2008:3
T
a
b
l
e
 
3
.
 
D
e
t
e
r
m
i
n
a
t
i
o
n
 
o
f
 
e
n
a
l
a
p
r
i
l
 
m
a
l
e
a
t
e
 
i
n
 
p
h
a
r
m
a
c
e
u
t
i
c
a
l
 
p
r
e
p
a
r
a
t
i
o
n
s
 
b
y
 
t
h
e
 
p
r
o
p
o
s
e
d
 
m
e
t
h
o
d
s
 
A
,
 
B
,
 
C
,
 
D
 
a
n
d
 
r
e
f
e
r
e
n
c
e
 
m
e
t
h
o
d
 
(
1
2
)
.
F
o
r
m
u
l
a
t
i
o
n
s
M
e
t
h
o
d
 
A
M
e
t
h
o
d
 
B
R
e
f
e
r
e
n
c
e
 
m
e
t
h
o
d
R
e
c
o
v
e
r
y
 
(
%
)
R
S
D
 
(
%
)
R
e
c
o
v
e
r
y
 
(
%
)
R
S
D
 
(
%
)
R
e
c
o
v
e
r
y
 
(
%
)
R
S
D
 
(
%
)
E
n
a
p
r
i
l
 
2
.
5
1
0
0
.
0
3
1
.
1
5
9
1
0
0
.
1
6
1
.
0
1
4
9
9
.
9
2
1
.
2
0
6
θ
L
 
=
 
0
.
9
9
3
θ
U
 
=
 
1
.
0
0
5
θ
L
 
=
 
0
.
9
9
2
θ
U
 
=
 
1
.
0
0
3
t
 
=
 
0
.
5
0
5
F
 
=
 
1
.
0
8
1
t
 
=
 
1
.
1
5
8
F
 
=
 
1
.
4
0
7
E
n
v
a
s
 
2
.
5
9
9
.
9
3
1
.
3
1
4
9
9
.
9
8
1
.
1
6
2
9
9
.
8
1
1
.
3
8
3
θ
L
 
=
 
0
.
9
8
8
θ
U
 
=
 
1
.
0
0
2
θ
L
 
=
 
0
.
9
9
1
θ
U
 
=
 
1
.
0
0
5
t
 
=
 
0
.
4
9
0
F
 
=
 
1
.
1
0
6
t
 
=
 
0
.
7
0
6
F
 
=
 
1
.
4
1
1
E
n
a
c
e
 
2
.
5
9
9
.
9
3
0
.
9
9
7
9
9
.
9
8
0
.
9
9
6
9
9
.
8
3
1
.
2
7
3
θ
L
 
=
 
0
.
9
9
3
θ
U
 
=
 
1
.
0
0
5
θ
L
 
=
 
0
.
9
9
3
θ
U
 
=
 
1
.
0
0
5
t
 
=
 
0
.
4
5
0
F
 
=
 
1
.
6
2
7
t
 
=
 
0
.
6
9
8
F
 
=
 
1
.
6
9
4
M
e
t
h
o
d
 
C
M
e
t
h
o
d
 
D
E
n
a
p
r
i
l
 
2
.
5
1
0
0
.
0
6
1
.
0
4
8
1
0
0
.
1
3
0
.
9
5
9
9
9
.
9
2
1
.
2
0
6
θ
L
 
=
 
0
.
9
9
3
θ
U
 
=
 
1
.
0
0
5
θ
L
 
=
 
0
.
9
8
5
θ
U
 
=
 
1
.
0
1
1
t
 
=
 
0
.
2
1
9
F
 
=
 
1
.
3
2
1
t
 
=
 
1
.
0
4
1
F
 
=
 
1
.
5
7
8
E
n
v
a
s
 
2
.
5
9
9
.
9
8
1
.
3
1
4
1
0
0
.
1
3
1
.
2
2
2
9
9
.
8
1
1
.
3
8
3
θ
L
 
=
 
0
.
9
9
1
θ
U
 
=
 
1
.
0
0
6
θ
L
 
=
 
0
.
9
9
0
θ
U
 
=
 
1
.
0
0
4
t
 
=
 
0
.
0
1
8
F
 
=
 
1
.
0
2
3
t
 
=
 
0
.
7
0
6
F
 
=
 
1
.
2
7
2
E
n
a
c
e
 
2
.
5
1
0
0
.
0
6
1
.
2
1
0
9
9
.
9
2
1
.
1
7
7
9
9
.
8
3
1
.
2
7
3
θ
L
 
=
 
0
.
9
9
6
θ
U
 
=
 
1
.
0
0
9
θ
L
 
=
 
0
.
9
9
3
θ
U
 
=
 
1
.
0
0
6
t
 
=
 
0
.
9
6
4
F
 
=
 
1
.
1
0
1
t
 
=
 
0
.
3
6
1
t
 
=
 
0
.
3
6
142
Rahman and Haque
Analytical Chemistry Insights 2008:3
Table 4. Application of the proposed spectrophotometric methods to the determination of enalapril maleate in 
spiked human urine.
Amount added (μg/mL) Amount found (μg/mL) % Recovery
Method A 10.0 9.83 98.30
25.0 24.63 98.52
40.0 39.56 98.91
x 98.58
RSD 0.31
Method B 80.0 79.14 98.92
320.0 319.25 99.76
480.0 474.28 98.81
x 99.16
RSD 0.52
Method C 20.0 19.45 97.25
40.0 38.78 96.96
100.0 99.52 99.52
x 97.91
RSD 1.43
Method D 40.0 39.57 98.93
80.0 79.83 99.78
160.0 158.70 99.19
x 99.30
RSD 0.44
and D) and reference method at 95% conﬁ  dence 
level regarding accuracy and precision. The results 
are summarized in Table 3. The proposed methods 
have been extended to the determination of enala-
pril maleate in spiked human urine samples. The 
results of analysis of urine samples are summarized 
in Table 4.
Conclusion
The proposed method does not require any labo-
rious clean up procedure before measurement. In 
addition, the method has wider linear dynamic 
range with good accuracy and precision. The 
methods show no interference from the common 
excipients and additives. The statistical parame-
ters and recovery data reveal the good accuracy 
and precision of the proposed methods. Therefore, 
it is concluded that the proposed methods are 
simple, sensitive and rapid for the determination 
of enalapril maleate in commercial dosage 
forms.
Acknowledgements
The authors are grateful to the Aligarh Muslim 
University, Aligarh for providing research facilities. 
Thanks are also extended to M/s Sunij Pharmaceu-
tical Private Limited, India, for providing a gift 
sample of pure enalapril maleate.
References
[1]  The United States Pharmacopia 28th Revision, 2005. The National 
Formulary, United States Pharmacopeial Convation., p.730.
[2]  Al-Momani, I.F. 2001. Determination of hydrochlorothiazide and 
enalapril maleate in tablet by reversed – phase HPLC. Turk J. Chem., 
25:49–54.
[3]  Thongnopnua, P. and Poeaknapo, C. 2005. High-performance liquid 
chromatographic determination of enalapril in human plasma by 
enzyme kinetic analytical method. J. Pharm. Biomed. Anal., 
37:763–69.
[4]  Tajerzadeh, H. and Hamidi, M. 2001. A simple HPLC method 
for quantitation of enalaprilat. J. Pharma. Biomed. Anal., 
24:675–80.
[5]  Qin, X-Z., Demarco, J. and Dominic, P.I. 1995. Simultaneous 
determination of enalapril, felodipine and their degradation 
products in the dosage formulation by reversed—phase high—
performance liquid chromatography using a Spherisorb C8 column. 
J. Chromatogr. A., 707:245–54.43
Determination of enalapril maleate by Spectrophotometry
Analytical Chemistry Insights 2008:3
[6]  Anzenbacherova, E., Anzenbacher, P., Macek, K. and Kvetina, J. 
2001. Determination of enzyme (angiotensin convertase) inhibitors 
based on enzymatic reaction followed by HPLC. J. Pharm. Biomed. 
Anal., 24:1151–6.
[7]  Pilatti, C., Ercolano, I., Del, M., Torre, C., Chiale, C. and Spinetto, M. 
1999. Search for related substance in market products containing 
enalapril maleate as the active principle. Drug Dev. Ind. Pharm., 
25:807–11.
[8]  Qinghua, G. and Jinlong, M. 1996. Determination of enalaprilat in 
injection by HPLC. Zhongguo Yiyao Gongye Zazhi, 27:415–6.
[9]  Walily, A.F.M.E., Belal, S.F., Heaba, E.A. and Kersh, A.E. 1995. 
Simultaneous determination of enalapril maleate and hydrochloro-
thiazide by ﬁ  rst-derivative ultraviolet spectrophotometry and high-
performance liquid chromatography. J. Pharm. Biomed. Anal., 
13:851–6.
[10]  Qin, X-Z., Dominic, P.I. and Tsai, E.W. 1992. Determination and 
rotamer separation enalapril maleate by capillary electrophoresis. 
J. Chromatogr. A., 626:251–8.
[11]  Gu, Q., Chen, X., Zhong, D. and Wang, Y. 2004. Simaltaneous 
determination of enalapril and enalaprilat in human plasma by liquid 
chromatography—tandem mass spectrometry. J. Chromatogr. B., 
813:337–42.
[12]  Razak, O.A., Belal, S.F., Bedair, M.M., Barakat, N.S. and Haggag, 
R.S. 2003. Spectrophotometric and polarographic determination of 
enalapril and lisinopril using 2,4-dinitroﬂ  urobenzene. J. Pharm. 
Biomed. Anal., 31:701–11.
[13]  Ayad, M.M., Shalaby, A.A., Abdellatef, H.E. and Hosny, M.M. 2002. 
Spectrophotometric and AAS determination of ramipril and enalapril 
through ternary complex formation. J. Pharm. Biomed. Anal., 
28:311–21.
[14]  Aboul-Enein, H.Y., Bunaciu, A.A., Bala, C. and Fleschin, S. 1997. Enala-
pril and Ramipril selective membranes. Anal. Lett., 30:1999–2008.
[15]  Chandwani, O.D., Dahibhati, P.P., Kadam, S.S. and Dhaneshwar, 
S.R. 1996. Simaltaneous spectrophotometric estimation of enalapril 
maleate and hydrochlorothiazide. Indian Drugs, 33:401–2.
[16]  Ayad, M.M., Shalaby, A.A., Abdellatef, H.E. and Hosny, M.M. 2003. 
Spectrophotometric methods for determination of enalapril and 
timolol in bulk and in drug formulations. Anal. Bioanal. Chem., 
375:556–60.
[17]  Feigl, F. 1960. Spot tests in organic analysis. Chapter 3: Preliminary 
(Exploratory tests), 6th ed., Elsevier publishing company, Amster-
dam 117–18.
[18]  Darwish, I.A. 2005. Analytical study for the charge-transfer com-
plexes of losartan potassium. Anal. Chim. Acta., 549:212–20.
[19]  Taha, A. and R.ücker, G. 1977. Utility of π-acceptors in alkaloid 
assay. Arch. Der. Pharm., 310:485–94.
[20]  Ross, S.D. and Labes, M.M. 1957. Molecular compounds. VIII. 
Evidence for the existence of 2:1 and 1:2-complexes in chloroform 
solutions of 1,3,5-trinitrobenzene and N., N.-dimethyl aniline. J. Am. 
Chem. Soc., 79:76–80.
[21]  Christan, G.D. 1994. Analytical Chemistry, 4th ed., John Wiley and 
Sons, Inc., Singapore.